• -
43 Results
US Capitol
A Need for Renewed and Cohesive U.S. Policy on Cord Blood Banking
While the Food and Drug Administration currently regulates storage and use of cord blood (CB) in the United States, other state and federal guidelines on CB education, awareness and ethical considerations remain variable, and no mandatory international guidelines exist. To help organize and coordinate efforts across the United States and other nations, policymakers should implement regulations for high quality standards for both private and public CB banks.
Monica M. Matsumoto, Kirstin R.W. Matthews August 4, 2015
Map of Middle East.
Cord Blood Banking in the Arab World: Current Status and Future Developments
In addition to their therapeutic potential, cord blood banks raise ethical and regulatory questions, especially in emerging markets in the Arab world. In this article, the authors review cord blood banking in five countries in the region (Jordan, Saudi Arabia, Egypt, Qatar, and the United Arab Emirates) that were selected for their different CB banking policies and initiatives.
Monica M. Matsumoto, Rana Dajani, Kirstin R.W. Matthews February 13, 2015
Globe showing Americas
Latin America Initiative | Journal
¿Reforma Política: Última Oportunidad? Ya No y Todavía No
The emphasis is on the deterioration of the participation of the political institutions and politicians before the citizenry in Costa Rica, which shows a process of exhaustion, loss of legitimacy of institutions and actors. This process goes back a few decades and shows no sign, in the short term, of the emergence of new structures in the political system. This paper systematizes the morphology of exhaustion and identifies the trends in which the reform can be based. Such reform should be based on constitutional engineering and should support the political reform process from the tendencies of change that are expressed in the political system. Published in Revista Derecho Electoral, December 2013. In Spanish only.
Constantino Urcuyo July 2, 2013
Doctor reviews large sheet of imaging output in a clinical hallway
Cancer Research in the United States: Dying by a Thousand Paper Cuts
In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.
Hagop M. Kantarjian, David J. Stewart, Leonard A. Zwelling June 6, 2013